ASTRAZENBSEASTRAZENECA PHARMA IND LT· PharmaceuticalsMinimalNeutral
Announced Tue, 27 Oct, 2026 · 24:53 IST

RTA confirms share dematerialisation compliance for September quarter

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.9%Reaction day
₹6050.00
prior close
₹5992.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Pharmaceuticals peers, median of 173sector+2.0%-1.1% vs sector

On the reaction day the stock moved 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.2
15m
+0.3
30m
+0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.9pendingpending+2.0-1.1
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the quarter ended September 30, 2026, the company's registrar and transfer agent certified that dematerialised securities were listed on the relevant exchanges, physical certificates were cancelled, and the depository was recorded as owner within 15 days of receiving certificates.

Likely market impact

This is routine shareholder servicing compliance with no change to operations or earnings. No material impact on the share price is expected.